NCT03842085
- Conditions
- HER2-positive Recurrent or Metastatic Malignant Solid Tumor, Neoplasm Metastasis, Neoplasms, +3 more
- Locations
-
- Henan Cancer Hospital Zhengzhou, China
Clinical trial condition
HER2-positive Recurrent or Metastatic Malignant Solid Tumor
Explore clinical trials studying HER2-positive Recurrent or Metastatic Malignant Solid Tumor. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study